Silitech Technology Corporation (3311.TW)
TWD 34.1
(-2.15%)
TWD 34.1
(-2.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 171.13 Million | 172.84 Million | 85.01 Million | -125.58 Million | 91.87 Million | -299 Million |
| Net Income | 119.32 Million | 134.65 Million | 89.41 Million | -305.33 Million | 1.08 Million | 43.05 Million |
| Depreciation & Amortization | 79.87 Million | 85.06 Million | 84.02 Million | 84.37 Million | 159.79 Million | 91.21 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -46.87 Million | -36.38 Million | -54.89 Million | -48.74 Million | -56.23 Million | -247.63 Million |
| Other non-cash items | 18.8 Million | -10.48 Million | -33.53 Million | 144.11 Million | -12.77 Million | -185.63 Million |
| Investing Cash Flow | -1.13 Billion | -57.51 Million | -511.84 Million | 92.31 Million | 347.07 Million | 1.24 Billion |
| Investments in PPE | -69.56 Million | -176.72 Million | -56.01 Million | -38.16 Million | -80 Million | -134.27 Million |
| Acquisitions | -56.66 Million | 52 Thousand | 1.15 Million | 29.37 Million | 67.31 Million | -26 Thousand |
| Investment purchases | -1.26 Billion | -52 Thousand | -452.53 Million | -72.1 Million | -658.27 Million | -2.23 Billion |
| Sales/Maturities of investments | 253.65 Million | 119.27 Million | -1.15 Million | 172.2 Million | 594.23 Million | 3 Billion |
| Other Investing Activities | 195 Thousand | -53 Thousand | -3.29 Million | 1 Million | 423.8 Million | 608.58 Million |
| Financing Cash Flow | -24.55 Million | -56.72 Million | 240.4 Million | -41.28 Million | -1.25 Billion | -1.23 Million |
| Debt repayment | -43.32 Million | -24.78 Million | -24.02 Million | -41.28 Million | -60.69 Million | -18.61 Million |
| Dividends payments | -40.8 Million | -31.96 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -1.19 Billion | - |
| Common Stock Issuance | - | - | 264 Million | - | -1.19 Billion | - |
| Other Financing Activities | 59.57 Million | 20 Thousand | 434 Thousand | -2000.00 | 6000.00 | -1.23 Million |
| Accounts receivables | -4.8 Million | -36.36 Million | 32.29 Million | 16.47 Million | 106.62 Million | -71.18 Million |
| Accounts payables | 11.16 Million | -22.85 Million | -51.01 Million | -42.95 Million | -72.5 Million | -37.31 Million |
| Inventory | -1.1 Million | -18.7 Million | -38.18 Million | -23.88 Million | -3.38 Million | -73.66 Million |
| Other working capital | -52.12 Million | 41.54 Million | 2.01 Million | 1.62 Million | -86.96 Million | -173.96 Million |
| Cash at beginning of period | 1.63 Billion | 1.49 Billion | 1.7 Billion | 1.85 Billion | 2.66 Billion | 1.71 Billion |
| Cash at end of period | 628.83 Million | 1.63 Billion | 1.49 Billion | 1.7 Billion | 1.85 Billion | 2.66 Billion |
| Capital Expenditure | -69.56 Million | -176.72 Million | -56.01 Million | -38.16 Million | -80 Million | -134.27 Million |
| Effect of forex changes on cash | -14.06 Million | 85.34 Million | -28.22 Million | -69.13 Million | 5.13 Million | -406 Thousand |
| Net cash flow / Change in cash | -1 Billion | 143.95 Million | -214.65 Million | -143.7 Million | -810.44 Million | 948.16 Million |
| Free Cash Flow | 101.56 Million | -3.88 Million | 29 Million | -163.75 Million | 11.86 Million | -433.27 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -37.48 Million | 27.09 Million | 22.82 Million | 27.22 Million | 119.32 Million | 47.48 Million |
| Depreciation & Amortization | 20.39 Million | 19.95 Million | 20.45 Million | 20.42 Million | 79.87 Million | 19.31 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 96.29 Million | -5.99 Million | -18.2 Million | 25.72 Million | -46.87 Million | -28.73 Million |
| Other non-cash items | 6.46 Million | 85.78 Million | 37.63 Million | 9.74 Million | 18.8 Million | -11.58 Million |
| Investing Cash Flow | 685 Thousand | 26.83 Million | -8.92 Million | -77.83 Million | -1.13 Billion | -207.55 Million |
| Investments in PPE | -14.01 Million | -6.78 Million | -12.97 Million | -24.08 Million | -69.56 Million | 20.05 Million |
| Acquisitions | 1.02 Million | 76 Thousand | 90 Thousand | - | -56.66 Million | -56.74 Million |
| Investment purchases | 180 Thousand | -84.9 Million | -19.4 Million | -102.15 Million | -1.26 Billion | -129.62 Million |
| Sales/Maturities of investments | 6.99 Million | 118.43 Million | 23.45 Million | 48.18 Million | 253.65 Million | 2.44 Million |
| Other Investing Activities | -68 Thousand | 13 Thousand | -89 Thousand | 218 Thousand | 195 Thousand | -43.67 Million |
| Financing Cash Flow | -88.1 Million | -6.4 Million | -6.17 Million | 36.39 Million | -24.55 Million | -47.55 Million |
| Debt repayment | - | -6.41 Million | -6.2 Million | -43.32 Million | -43.32 Million | -6.78 Million |
| Dividends payments | -81.6 Million | - | - | - | -40.8 Million | -40.8 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -6.5 Million | 11 Thousand | 27 Thousand | 79.72 Million | 59.57 Million | 35 Thousand |
| Accounts receivables | -16.18 Million | -59.14 Million | 35.24 Million | 50.44 Million | -4.8 Million | -34.79 Million |
| Accounts payables | 31.43 Million | 26.12 Million | -12.38 Million | -46.12 Million | 11.16 Million | 35.2 Million |
| Inventory | 10.13 Million | -7.91 Million | -9.47 Million | 20.27 Million | -1.1 Million | -32.03 Million |
| Other working capital | 70.9 Million | 34.94 Million | -31.58 Million | 1.13 Million | -52.12 Million | 2.89 Million |
| Cash at beginning of period | 734.2 Million | 660.57 Million | 628.83 Million | 604.79 Million | 1.63 Billion | 804.05 Million |
| Cash at end of period | 802.5 Million | 734.2 Million | 660.57 Million | 628.83 Million | 628.83 Million | 604.79 Million |
| Capital Expenditure | -14.01 Million | -6.78 Million | -12.97 Million | -24.08 Million | -69.56 Million | 20.05 Million |
| Effect of forex changes on cash | - | 7.21 Million | 11.65 Million | -15.34 Million | -14.06 Million | 29.35 Million |
| Net cash flow / Change in cash | 68.29 Million | 73.63 Million | 31.73 Million | 24.04 Million | -1 Billion | -199.26 Million |
| Free Cash Flow | 71.65 Million | 39.21 Million | 22.2 Million | 59.03 Million | 101.56 Million | 46.53 Million |
BORORENEW
BIOTEC
SLM
1512
1009
BCSO